Women taking daily doses thyroid treatment synthroid alternative 1.6 mcg/kg or more had significantly lower bone thyroid treatment synthroid alternative density levels at the ultradistal radius, midshaft radius, hip, and lumbar spine compared thyroid treatment synthroid alternative controls. If it is almost time for your next dose, skip the one you missed and go back to your regular schedule. This drug does pass into breast milk, but it is not expected to be harmful to a nursing infant. If it is almost time for your next dose, skip the one you missed and go back to your regular schedule. The patient should be monitored closely to avoid undertreatment or overtreatment.
synthroid for hypertension
PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. thyroid treatment synthroid alternative your pharmacist how you should take your brand of thyroid treatment synthroid alternative The information contained herein is not intended to cover all possible uses, directions, precautions, thyroid treatment synthroid alternative drug interactions, allergic reactions, or adverse effects. Package Label.Principal Display Panel NDC 0074-6624-19 1000 TABLETS Synthroid® (levothyroxine sodium tablets, USP) 100 mcg (0.1 mg) Rx only NSN 6505-01-042-9260 Do not accept if seal over bottle opening is broken or missing. Cardiovascular side effects have included symptoms of palpitations, hypertension, tachycardia, and angina which may be exacerbated in patients with underlying cardiovascular disorders. It does not contain all information about Synthroid. Tell your health care provider if you are taking any other medicines, especially any of the following: Many prescription and nonprescription medicines (eg, used for infections, inflammation, aches and pains, nasal congestion, asthma, high blood pressure, irregular heartbeat or other heart problems, blood thinning, mental or mood problems, depression, diabetes, other thyroid problems, high cholesterol, hepatitis, weight loss, heartburn, birth control, hormone replacement therapy, thyroid treatment synthroid alternative hormone deficiency, cancer, seizures), and thyroid treatment synthroid alternative products may interact with Synthroid, increasing the risk of side effects or decreasing effectiveness. Even if you feel well, thyroid treatment synthroid alternative may still need to take this medicine every day for the rest of your life to replace the thyroid hormone your body cannot produce. thyroid treatment synthroid alternative alcohol or tobacco with certain medicines may also cause interactions to occur. Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Therapeutic effect of digitalis glycosides may be reduced. --Storage instructions... Maternal hypothyroidism may have an adverse effect on fetal and childhood growth and development. This drug thyroid treatment synthroid alternative pass into breast milk, but it is not expected to be harmful to a nursing infant. 2 Product Characteristics Color BLUE Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;150 Contains Packaging thyroid treatment synthroid alternative NDC Package Description Multilevel Packaging 1 0074-7069-13 100 TABLET In 1 BOTTLE None 2 0074-7069-71 28 TABLET In 1 BOX None 3 0074-7069-19 1000 TABLET In 1 BOTTLE None thyroid treatment synthroid alternative 0074-7069-11 10 BLISTER PACK In 1 BOX, UNIT-DOSE contains a BLISTER PACK 4 10 TABLET In 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (0074-7069-11) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-7070 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name thyroid treatment synthroid alternative of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 175 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC FD&C BLUE thyroid treatment synthroid alternative Drugs that may alter T4 and T3 metabolism Drugs that may increase hepatic metabolism, which may result in hypothyroidism Carbamazepine Hydantoins Phenobarbital Rifampin Stimulation of hepatic microsomal thyroid treatment synthroid alternative enzyme activity may cause increased hepatic degradation of levothyroxine, resulting in increased levothyroxine requirements. Protect from heat, light, and moisture. 1 Product Characteristics Color GREEN Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;300 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-7149-13 100 TABLET In 1 BOTTLE None 2 0074-7149-19 1000 TABLET In 1 BOTTLE None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-4341 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 25 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC FD&C YELLOW NO. Patients with coronary artery disease who are receiving levothyroxine therapy should be monitored closely during surgical procedures, since the possibility of precipitating cardiac arrhythmias may be greater in those treated with levothyroxine. 1 Product Characteristics Color BROWN Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;125 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-7068-13 100 TABLET In 1 BOTTLE None 2 0074-7068-71 28 TABLET In 1 BOX None thyroid treatment synthroid alternative 0074-7068-19 1000 TABLET In 1 BOTTLE None 4 0074-7068-11 10 BLISTER PACK In 1 BOX, UNIT-DOSE contains a BLISTER PACK 4 10 TABLET In 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (0074-7068-11) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN thyroid treatment synthroid alternative DRUG NDC Product Code (Source) 0074-3727 Route of thyroid treatment synthroid alternative ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 137 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC FD&C BLUE NO.
What happens if I overdose? Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. Ask your health care provider if Synthroid may interact with other medicines that you take. thyroid treatment synthroid alternative thyroid treatment synthroid alternative Characteristics Color BLUE Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;150 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-7069-13 100 TABLET In 1 BOTTLE None 2 0074-7069-71 28 TABLET In 1 BOX None 3 0074-7069-19 1000 TABLET In 1 BOTTLE None 4 0074-7069-11 10 BLISTER PACK In 1 BOX, UNIT-DOSE contains a BLISTER PACK 4 10 TABLET In 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (0074-7069-11) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-7070 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 175 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC FD&C BLUE NO. The liver thyroid treatment synthroid alternative the major site of degradation for both T4 and T3, thyroid treatment synthroid alternative T4 deiodination also occurring at a number of additional sites, including the kidney and other tissues. People with very serious conditions caused by too little thyroid hormone may thyroid treatment synthroid alternative higher thyroid treatment synthroid alternative dose is based on body weight and must be determined by your doctor . Precautions While Using Synthroid It is very important that your doctor check your progress at regular visits. They are supplied as follows: Strength (mcg) Color NDC # for bottles of 100 NDC # for bottles of 1000 NDC # for unit dose thyroid treatment synthroid alternative of 100 25 orange 0074-4341-13 0074-4341-19 -- 50 white 0074-4552-13 0074-4552-19 0074-4552-11 75 violet 0074-5182-13 0074-5182-19 0074-5182-11 88 olive 0074-6594-13 0074-6594-19 -- 100 yellow 0074-6624-13 0074-6624-19 0074-6624-11 112 rose 0074-9296-13 0074-9296-19 -- 125 brown 0074-7068-13 0074-7068-19 0074-7068-11 137 turquoise 0074-3727-13 0074-3727-19 -- 150 blue 0074-7069-13 0074-7069-19 0074-7069-11 175 lilac 0074-7070-13 0074-7070-19 -- 200 pink 0074-7148-13 0074-7148-19 0074-7148-11 300 green 0074-7149-13 0074-7149-19 -- Storage Conditions Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F) . Dosage adjustment may be needed . Proper Use of Synthroid Dosing The dose of this medicine will be different for different patients. Levothyroxine is contraindicated in patients with uncorrected adrenal insufficiency since thyroid hormones may precipitate an acute adrenal crisis by increasing the metabolic clearance of thyroid treatment synthroid alternative (see PRECAUTIONS). Therefore, the possibility of fetal harm appears remote. thyroid treatment synthroid alternative three weeks after initiating treatment, the patient reported intermittent chest pains during thyroid treatment synthroid alternative course of treatment, and a coronary artery angiogram revealed diffuse stenosis of all 3 branches. Although there has been a reported association between prolonged thyroid hormone therapy and breast cancer, this has not been confirmed. Drug-Thyroidal Axis Interactions thyroid treatment synthroid alternative or Drug Class Effect Drugs that may reduce TSH secretion – the reduction is not sustained; therefore, hypothyroidism does not occur Dopamine/Dopamine Agonists Glucocorticoids Octreotide Use of these agents may result in a transient reduction in TSH secretion when administered at the following doses: Dopamine (≥ 1 mcg/kg/min); Glucocorticoids (hydrocortisone ≥ 100 mg/day or equivalent); Octreotide (> 100 mcg/day). Contact your doctor if hair loss is severe or persistent. Seizures have occurred in a child ingesting 18 mg of levothyroxine.